Organisation paid for research Program year 2024 Source: CMS Open Payments

Tennessee Retina

Neither a doctor nor a teaching hospital

Research payments

$3,053,061

252 payments

Through program year 2024, Tennessee Retina is reported as receiving $3,053,061 in research payments, across 252 payments.

By program year

5 rows

Year	Kind	Amount	Payments
2024	Research	$80,314	4
2023	Research	$93,472	2
2021	Research	$1,181,491	87
2020	Research	$1,074,700	64
2019	Research	$623,085	95

Breakdown

Who paid Research payments · program years 2019–2024

Genentech, Inc. $2,875,000 196 payments
EyePoint Pharmaceuticals US, Inc. $92,822 1 payment
Alimera Sciences, Inc. $80,964 5 payments
Mylan Technologies Inc. $4,276 50 payments

Studies the money was for Research payments · program years 2019–2024

Study of the Port Delivery System With Ranibizumab in Patients With Diabetic MacUlar Edema $685,381 15 payments
Port Delivery System for Ranibizumab $570,328 24 payments
Port Delivery System of Ranizibumab Extension Study $366,101 21 payments
Va2 Phiii $293,996 16 payments
Lucentis Fsv4 Lad Amd Ladder $240,644 63 payments
Phase 2 of Ro7171009 in Ga $192,083 12 payments
Va2 Phiii Rhine $182,207 19 payments
Port Delivery System of Ranibizumab Extension Study $174,830 3 payments
Fluocinolone Acetonide Intravitreal Implant 0.18 mg in the Treatment of Chronic Non-Infectious Posterior Segment Uveitis $92,822 1 payment
A Phase III Multicenter Observation Comparator Study of the Efficacy Safety and Pharmacokinetics $90,904 10 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.